【肝癌】利用ML預測接受癌自禦合併癌思停治療的末期肝癌總存活期和無惡化存活期

 【肝癌】利用機器學習預測接受癌自禦合併癌思停治療的末期肝癌總存活期和無惡化存活期

 文章出處  

THE LANCET Digital Health 

 

 原文標題  

The use of advanced machine learning to predict outcomes after atezolizumab plus bevacizumab for advanced hepatocellular carcinoma: a retrospective cohort study 

 

 文章序號  

11003 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2026 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.